Table: Garna Biosciences - 6-MTH group results

Carna Biosciences

07/08/2023 07:30

Aug 7 (Reuters)- 
             Garna Biosciences Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to   
                Jun 30, 2023        Jun 30, 2022       Dec 31, 2023  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            500 mln             839 mln           902 mln     
                 (-40.4 pct)         (+95.2 pct)       (-34.9 pct)   
  Operating     loss 863 mln        loss 312 mln        loss 1.89    
  Recurring     loss 868 mln        loss 306 mln        loss 1.91    
  Net           loss 885 mln        loss 359 mln        loss 1.94    
  EPS          loss 53.81 yen      loss 26.53 yen    loss 125.25 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - Garna Biosciences Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T